Literature DB >> 23938941

Prostate cancer: MRI/US-guided biopsy--a viable alternative to TRUS-guidance.

Wendy J M van de Ven1, Jelle O Barentsz.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23938941     DOI： 10.1038/nrurol.2013.179

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

Review 1.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.

Authors:  Caroline M Moore; Nicola L Robertson; Nasr Arsanious; Thomas Middleton; Arnauld Villers; Laurence Klotz; Samir S Taneja; Mark Emberton
Journal:  Eur Urol       Date:  2012-06-13       Impact factor: 20.096

2.  Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.

Authors:  Thomas Hambrock; Caroline Hoeks; Christina Hulsbergen-van de Kaa; Tom Scheenen; Jurgen Fütterer; Stefan Bouwense; Inge van Oort; Fritz Schröder; Henkjan Huisman; Jelle Barentsz
Journal:  Eur Urol       Date:  2011-08-27       Impact factor: 20.096

3.  Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.

Authors:  Caroline M A Hoeks; Martijn G Schouten; Joyce G R Bomers; Stefan P Hoogendoorn; Christina A Hulsbergen-van de Kaa; Thomas Hambrock; Henk Vergunst; J P Michiel Sedelaar; Jurgen J Fütterer; Jelle O Barentsz
Journal:  Eur Urol       Date:  2012-02-01       Impact factor: 20.096

4.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.

Authors:  Geoffrey A Sonn; Edward Chang; Shyam Natarajan; Daniel J Margolis; Malu Macairan; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Robert E Reiter; Leonard S Marks
Journal:  Eur Urol       Date:  2013-03-17       Impact factor: 20.096

5.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies.

Authors:  Nicolas Barry Delongchamps; Michaël Peyromaure; Alexandre Schull; Frédéric Beuvon; Naïm Bouazza; Thierry Flam; Marc Zerbib; Naira Muradyan; Paul Legman; François Cornud
Journal:  J Urol       Date:  2012-10-08       Impact factor: 7.450

6.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.

Authors:  Philippe Puech; Olivier Rouvière; Raphaele Renard-Penna; Arnauld Villers; Patrick Devos; Marc Colombel; Marc-Olivier Bitker; Xavier Leroy; Florence Mège-Lechevallier; Eva Comperat; Adil Ouzzane; Laurent Lemaitre
Journal:  Radiology       Date:  2013-04-11       Impact factor: 11.105

7.  Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies.

Authors:  Wendy J M van de Ven; Christina A Hulsbergen-van de Kaa; Thomas Hambrock; Jelle O Barentsz; Henkjan J Huisman
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

8.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.

Authors:  M Minhaj Siddiqui; Soroush Rais-Bahrami; Hong Truong; Lambros Stamatakis; Srinivas Vourganti; Jeffrey Nix; Anthony N Hoang; Annerleim Walton-Diaz; Brian Shuch; Michael Weintraub; Jochen Kruecker; Hayet Amalou; Baris Turkbey; Maria J Merino; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  Eur Urol       Date:  2013-06-12       Impact factor: 20.096

9.  MR to ultrasound registration for image-guided prostate interventions.

Authors:  Yipeng Hu; Hashim Uddin Ahmed; Zeike Taylor; Clare Allen; Mark Emberton; David Hawkes; Dean Barratt
Journal:  Med Image Anal       Date:  2010-12-13       Impact factor: 8.545

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315
  10 in total
  6 in total

1.  Direct MRI-guided biopsy of the prostate: use of post-biopsy needle track imaging to confirm targeting.

Authors:  Alexander J Nicholson; David R Pettersson; Elena K Korngold; Bryan R Foster; Arthur Y Hung; Christopher L Amling; Fergus V Coakley
Journal:  Abdom Imaging       Date:  2015-10

Review 2.  Magnetic resonance-ultrasound fusion prostate biopsy in the diagnosis of prostate cancer.

Authors:  Mark D Tyson; Sandeep S Arora; Kristen R Scarpato; Daniel Barocas
Journal:  Urol Oncol       Date:  2016-04-12       Impact factor: 3.498

3.  Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.

Authors:  Yajuan Li; Zheng Han; Sarah Roelle; Aidan DeSanto; Rob Sabatelle; Rebecca Schur; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939

4.  Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.

Authors:  Thais Caldara Mussi; Rodrigo Gobbo Garcia; Marcos Roberto Gomes Queiroz; Gustavo Caserta Lemos; Ronaldo Hueb Baroni
Journal:  Int Braz J Urol       Date:  2016 Sep-Oct       Impact factor: 1.541

5.  Contemporary outcomes in the detection of prostate cancer using transrectal ultrasound-guided 12-core biopsy in Singaporean men with elevated prostate specific antigen and/or abnormal digital rectal examination.

Authors:  Alvin Lee; Sing Joo Chia
Journal:  Asian J Urol       Date:  2015-09-03

Review 6.  Direct magnetic resonance imaging-guided biopsy of the prostate: lessons learned in establishing a regional referral center.

Authors:  Benjamin Addicott; Bryan R Foster; Chenara Johnson; Alice Fung; Christopher L Amling; Fergus V Coakley
Journal:  Transl Androl Urol       Date:  2017-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.